SCA4 Unravelled After More than 25 Years Using Advanced Genomic Technologies
Mov Disord
.
2024 Mar;39(3):457-461.
doi: 10.1002/mds.29738.
Authors
Laura Ivete Rudaks
1
2
3
4
5
,
Dennis Yeow
1
2
3
4
6
7
,
Kishore Raj Kumar
1
2
3
4
8
Affiliations
1
Translational Neurogenomics Group, Concord Repatriation General Hospital, Concord, Australia.
2
Molecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, Concord, Australia.
3
Concord Clinical School, Faculty of Medicine and Health, The University of Sydney, Concord, Australia.
4
Genomic and Inherited Disease Program, The Garvan Institute of Medical Research, Darlinghurst, Australia.
5
Clinical Genetics Unit, Royal North Shore Hospital, St Leonards, Australia.
6
Neurodegenerative Service, Prince of Wales Hospital, Randwick, Australia.
7
Neuroscience Research Australia, Randwick, Australia.
8
St Vincent's Healthcare Campus, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Darlinghurst, Australia.
PMID:
38525586
DOI:
10.1002/mds.29738
No abstract available
Publication types
Editorial
MeSH terms
Genomics*
Humans
Grants and funding
2024888/Medical Research Future Fund
2023357/Medical Research Future Fund
2023126/Medical Research Future Fund